Top Markets
#1 SuperVerse SuperVerse +20.75%
#2 Audiera Audiera +17.73%
#3 Win Win +15.98%
#4 Qkacoin Qkacoin +9.75%
#5 TRIA TRIA +7.94%
#6 Ontology Ontology +6.73%
#7 Shuffle Shuffle +6.73%
#8 Testicle Testicle +5.42%
#9 Hive Hive +4.90%
#10 Siren Siren +4.76%
Coin of the day
SuperVerse SuperVerse
Settings
Language
ENGLISH
Currency
USD
Theme
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rank in Stocks #18703
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Share Price
$2.49
Market Cap
$4.47M
Change (1 day)
-4.01%
Change (1 year)
678.16%
Country
MY
Trade BioNexus Gene Lab Corporation (BGLC)

Category

Healthcare
P/E ratio for BioNexus Gene Lab Corporation (BGLC)
P/E ratio as of March 2026 TTM: -1.75
According to BioNexus Gene Lab Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.75. At the end of 2023 the company had a P/E ratio of -3.47.
P/E ratio history for BioNexus Gene Lab Corporation from 2016 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -1.75 -43.84%
2024 -3.12 -10.09%
2023 -3.47 -99.25%
2022 -461.48 -195.07%
2021 485.43 134.48%
2020 207.02 -126.84%
2019 -771.23 -113.97%
2018 5.52K -515.82%
2017 -1.33K -99.33%
2016 -196.70K 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 26.00 -1,583.96%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 36.66 -2,192.26%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 43.38 -2,575.81%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
2359.HK
 17.18 -1,080.41%
CN
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
 24.46 -1,496.13%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.